Senior Trial Manager

BSc (Hons), PhD

Email: kmw36@medschl.cam.ac.uk | Tel: 01223 (3)30332 | Office: Strangeways’ Research Laboratory | ORCID

Background

With a background in scientific laboratory-based research, Kate gained her PhD in the Medical Faculty at the University of Bristol, where she worked for eight years. In 2001 she joined the Department of Public Health & Primary Care here at the University of Cambridge as a trial co-ordinator for the ProActive study, the Unit’s first randomised controlled trial. She then worked on the ADDITION studies, a series of studies investigating screening for and intensive treatment of diabetes in primary care. Kate was involved with two recent Unit studies funded by the NIHR School for Primary Care Research; the long-term follow-up of both the ProActive and ADDITION cohorts. She lead the co-ordination of the Get Moving Study and the SeRaHS study (Self-rated Health in Stroke), the PosMT after Stroke pilot, and worked with the MRC Epidemiology Unit on the FMR Study. Kate most recently lead the management of the PROPS Trial, part of the PolyPill Programme and is now managing the atrial fibrillation programme (SAFER Study).

Research Interests

In addition to various trial-specific co-ordination responsibilities, Kate provides Unit-wide support and guidance on all trial management, ethical and regulatory issues. Kate is also the primary liaison point for the Unit with the Cambridge Clinical Trials Unit, as well as for the local CRN and the RDS teams.

With an active interest in ethics and patient and public involvement (PPI) in research and clinical medicine, Kate is a lay member of a local NHS Research Ethics Committee.